These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 31028714)
1. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer. Tian S; Zhan N; Li R; Dong W Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714 [TBL] [Abstract][Full Text] [Related]
2. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells. Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A Gene; 2023 Aug; 877():147548. PubMed ID: 37279863 [TBL] [Abstract][Full Text] [Related]
3. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients. Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074 [TBL] [Abstract][Full Text] [Related]
4. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines. Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077 [TBL] [Abstract][Full Text] [Related]
5. Mining the role of RECQL5 in gastric cancer and seeking potential regulatory network by bioinformatics analysis. Lin Y; Chen H; Wang X; Xiang J; Wang H; Peng J Exp Mol Pathol; 2020 Aug; 115():104477. PubMed ID: 32497619 [TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047 [TBL] [Abstract][Full Text] [Related]
7. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer. Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381 [TBL] [Abstract][Full Text] [Related]
8. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value. He XY; Zhao J; Chen ZQ; Jin R; Liu CY Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694 [TBL] [Abstract][Full Text] [Related]
9. Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance. Wu PL; He YF; Yao HH; Hu B Med Sci Monit; 2018 Jan; 24():348-355. PubMed ID: 29343680 [TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen. Ignatov T; Claus M; Nass N; Haybaeck J; Seifert B; Kalinski T; Ortmann O; Ignatov A Breast Cancer Res Treat; 2019 Feb; 174(1):121-127. PubMed ID: 30478785 [TBL] [Abstract][Full Text] [Related]
12. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells. Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276 [TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer. Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952 [TBL] [Abstract][Full Text] [Related]
14. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis. Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R Cells; 2020 Mar; 9(3):. PubMed ID: 32143514 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer. Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123 [TBL] [Abstract][Full Text] [Related]
16. The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer. Friese K; Kost B; Vattai A; Marmé F; Kuhn C; Mahner S; Dannecker C; Jeschke U; Heublein S J Cancer Res Clin Oncol; 2018 Jan; 144(1):13-19. PubMed ID: 28924735 [TBL] [Abstract][Full Text] [Related]
17. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail. Wang Z; Chen X; Zhao Y; Jin Y; Zheng J J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688 [TBL] [Abstract][Full Text] [Related]
18. Expression of G protein-coupled oestrogen receptor in melanoma and in pregnancy-associated melanoma. Fábián M; Rencz F; Krenács T; Brodszky V; Hársing J; Németh K; Balogh P; Kárpáti S J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1453-1461. PubMed ID: 28467693 [TBL] [Abstract][Full Text] [Related]
19. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer. Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983 [TBL] [Abstract][Full Text] [Related]
20. G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells. Jiang X; Ye X; Ma J; Li W; Wu R; Jun L Gynecol Endocrinol; 2015; 31(11):894-8. PubMed ID: 26416628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]